T790M Plasma Testing Methodology comparison and clinical validation

Trial Identifier: D5160C00042
Sponsor: AstraZeneca
Collaborator:
Tigermed
NCTID:: NCT02997501
Start Date: December 2016
Primary Completion Date: October 2018
Study Completion Date: October 2018
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Chinese (Simplified) Translation

Trial Locations

Country Location
CN Changchun, CN, 130012
CN Chengdu, CN, 610041
CN Guangzhou, CN, 510080
CN Wuhan, CN, 430030
CN Wuhan, CN, 430022
CN Wuhan, CN, 430079
CN xi'an, CN, 710038